The? cost? of? discovering? new? drugs? has? increased? significantly,? and? pharmaceutical? Multinational? Corporations? (MNCs)? have? market? pressures? to? decrease? prices? of? drugs. Moreover, the ?patents ?of ?numerous? blockbusters ?will? expire ?within ?the? next? few? years? and? the? MNCs? are? still? not? able? to? replace? them? with? new? profitable? blockbusters. ?Moreover,? companies? from? developing ?countries ?are ?trying? their? best? to? move? up? the? value? chain.? A? country? like? India? has? some? essential? advantages? in? terms? of ?cost ?reduction ?and ?access? to? highly skilled? labour? at ?lower ?cost. ?Therefore? it? is? assumed? that? the? developing? countries? might? have? the? potential? to? become? R&D? clusters.? This? work? will? try? to? identify? some? essential? factors? that? may? indicate? whether? India? has? the? potential? to? become? an? R&D? cluster? for? biopharmaceuticals.??Über den Autor:
Abtin Maghrour, MSc: Studies Science & Technology Policy & Management at the University of Edinburgh, MA: Studied Strategy and Marketing at the University of Applied Sciences Darmstadt. Consultant at Capco, Frankfurt.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.